Tag: Valoctocogene roxaparvovec

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Valoctocogene roxaparvovec

Sigilon hold hurts ahead of key haemophilia meeting

Added to Collection on: 2021-07-12 14:58:09

Tags for this article:

Haemophilia
Branches of biology
Life Sciences
Biology
Valoctocogene roxaparvovec
BioMarin Pharmaceutical
Gene therapy
Emicizumab
Haemophilia A
International Society on Thrombosis and Haemostasis
Factor VIII
Spark Therapeutics

Click the tags to see associated articles and topics

View Article Details
New Data Reinforce Safety Profile of Emicizumab in Patients with Hemophilia A

Added to Collection on: 2021-07-20 18:22:30

Tags for this article:

Blood
Coagulation system
Haemophilia
Branches of biology
Anatomy
Emicizumab
Haemophilia A
Genentech
Factor VII
Coagulation
Bleeding
Valoctocogene roxaparvovec

Click the tags to see associated articles and topics

View Article Details
BioMarin Announces Second Quarter 2021 Financial Results and Corporate Updates

Added to Collection on: 2021-07-28 20:03:45

Tags for this article:

Orphan drugs
Drugs
Accounting
Health care
BioMarin Pharmaceutical
Iduronidase
Valoctocogene roxaparvovec
Income statement
Elosulfase alfa
Deferred tax
Provision
Generally Accepted Accounting Principles
BioMarin Pharmaceutical Inc.
Vimizim
Kuvan
Firdapse
United States
Naglazyme
Aldurazyme

Click the tags to see associated articles and topics

View Article Details
BioMarin's dwarfism drug Voxzogo scores European nod for young children, awaits looming ...

Added to Collection on: 2021-08-27 16:41:15

Tags for this article:

Health sciences
Health
Orphan drugs
Growth disorders
Rare diseases
Dwarfism
Vosoritide
BioMarin Pharmaceutical
Achondroplasia
Valoctocogene roxaparvovec
Osteochondrodysplasia
Fibroblast growth factor receptor 3
BioMarin

Click the tags to see associated articles and topics

View Article Details
BioMarin Pharmaceutical (NASDAQ:BMRN) Earns Outperform Rating from Wedbush | MarketBeat

Added to Collection on: 2021-10-29 12:07:14

Tags for this article:

Finance
Money
Economy
Orphan drugs
BioMarin Pharmaceutical
Virotherapy
Short
Stock
Valoctocogene roxaparvovec
Dividend
Price?earnings ratio
Securities research

Click the tags to see associated articles and topics

View Article Details
Bbva USA Purchases 159 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - ETF ...

Added to Collection on: 2022-01-03 00:01:17

Tags for this article:

Orphan drugs
Financial markets
Health care
Drugs
BioMarin Pharmaceutical
Stock
Price?earnings ratio
Valoctocogene roxaparvovec
Vosoritide
Dividend
BioMarin Pharmaceutical Inc.
BBVA USA

Click the tags to see associated articles and topics

View Article Details
BioMarin Announces Stable and Durable Annualized Bleed Control in the Largest Phase 3 ...

Added to Collection on: 2022-01-09 20:26:59

Tags for this article:

Branches of biology
Life Sciences
Blood
Coagulation system
Haemophilia
Orphan drugs
Virotherapy
Gene therapy
Valoctocogene roxaparvovec
BioMarin Pharmaceutical
Factor VIII
Haemophilia A
BioMarin Pharmaceutical Inc.

Click the tags to see associated articles and topics

View Article Details
BioMarin preaches patience amid slow sales for hemophilia gene therapy | BioPharma Dive

Added to Collection on: 2024-02-23 15:00:04

Tags for this article:

BioMarin Pharmaceutical
Virotherapy
Orphan drugs
Biotechnology
Leerink Partners
Valoctocogene roxaparvovec
Gene therapy
Medication
Therapy
Alex Hardy

Click the tags to see associated articles and topics

View Article Details
BioMarin Stands Firm on 2027 Revenue Target Amid Ascendis Competition, Goldman ...

Added to Collection on: 2024-09-25 22:18:13

Tags for this article:

Orphan drugs
BioMarin Pharmaceutical
Virotherapy
Financial markets
Vosoritide
Goldman Sachs
Earnings guidance
Valoctocogene roxaparvovec
Piper Sandler Companies
Gene therapy
Overweight
BioMarin Pharmaceutical Inc.
Ascendis Pharma A/S
Ascendis Pharma

Click the tags to see associated articles and topics

View Article Details